Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study
Open Access
- 12 March 2009
- journal article
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
- Vol. 3 (1) , 9
Abstract
Objective: The objective of this study was to compare intramuscular (IM) ziprasidone to conventional IM medications (haloperidol combined with lorazepam) for the treatment of severe agitation in adolescents (age 12–17). Methods: We retrospectively identified consecutive severe agitation episodes (defined as requiring physical restraint) in adolescents treated with either IM ziprasidone or conventional IM agents in a psychiatric emergency room. For ziprasidone, the dosage was 20 mg for 23 episodes and 10 mg for 5 episodes. For 24 episodes treated with combined haloperidol and lorazepam, the dosages were 4.8 ± 0.3 SEM mg and 1.9 ± 0.4 mg respectively. Outcomes were the duration of restraint and need for adjunctive "rescue" medications within 60 minutes. These outcomes were decided prior to reviewing any records. Results: No difference was found in restraint duration (ziprasidone, N = 28, 55 ± 5 minutes; haloperidol with lorazepam N = 24, 65 ± 7 minutes, P = NS). Use of "rescue" medications did not differ between the two groups. No changes in blood pressure were found, but pulse decreased 8.3 ± 2.4 for haloperidol with lorazepam and 8.9 ± 4.24 for ziprasidone (P = NS). No instances of excessive sedation or extra-pyramidal symptoms were documented. Conclusion: In this study, IM ziprasidone appeared effective, well tolerated, and similar in clinical profile to combined conventional IM medications for treating severe agitation in adolescents. Given the reportedly favorable acute side effect profile of parenteral atypical agents, they may provide an alternative to conventional antipsychotics for treating acute agitation in both adult and adolescent populations. Future randomized, controlled studies are needed.Keywords
This publication has 19 references indexed in Scilit:
- A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With SchizophreniaAmerican Journal of Psychiatry, 2008
- Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar ManiaAmerican Journal of Psychiatry, 2007
- A Retrospective Chart Review of Intramuscular Ziprasidone for Agitation in Children and Adolescents on Psychiatric Units: Prospective Studies Are NeededJournal of Child and Adolescent Psychopharmacology, 2007
- A Naturalistic Evaluation of Intramuscular Ziprasidone Versus Intramuscular Olanzapine for the Management of Acute Agitation and Aggression in Children and AdolescentsJournal of Child and Adolescent Psychopharmacology, 2006
- Introduction: Methods, Commentary, and SummaryJournal of Psychiatric Practice, 2005
- Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic studyGeneral Hospital Psychiatry, 2005
- Intramuscular Ziprasidone in Youth: A Retrospective Chart ReviewJournal of Child and Adolescent Psychopharmacology, 2004
- Intramuscular Ziprasidone for Acute Agitation in AdolescentsJournal of Child and Adolescent Psychopharmacology, 2004
- Risperidone in Children with Autism and Serious Behavioral ProblemsNew England Journal of Medicine, 2002
- Intramuscular Ziprasidone Compared With Intramuscular Haloperidol in the Treatment of Acute PsychosisThe Journal of Clinical Psychiatry, 2000